| 1. |
Mochizuki, K.
Kudo, S. E.
Kato, K.
Kudo, K.
Ogawa, Y.
Kouyama, Y.
Takashina, Y.
Ichimasa, K.
Tobo, T.
Toshima, T.
Hisamatsu, Y.
Yonemura, Y.
Masuda, T.
Miyachi, H.
Ishida, F.
Nemoto, T.
Mimori, K., Molecular and clinicopathological differences between depressed and protruded T2 colorectal cancer, PLoS One. , 2022;17(10):e0273566., 2022.06. |
| 2. |
Ozato, Y.
Masuda, T.
Kobayashi, Y.
Takao, S.
Hisamatu, Y.
Toshima, T.
Yonemura, Y.
Uemura, M.
Eguchi, H.
Doki, Y.
Mori, M.
Mimori, K., PRKRIP1, A Splicing Complex Factor, Is a Marker of Poor Prognosis in Colorectal Cancer, Anticancer Res. , 2022;42(10):4701-6., 2022.06. |
| 3. |
Shimizu, D.
Taniue, K.
Matsui, Y.
Haeno, H.
Araki, H.
Miura, F.
Fukunaga, M.
Shiraishi, K.
Miyamoto, Y.
Tsukamoto, S.
Komine, A.
Kobayashi, Y.
Kitagawa, A.
Yoshikawa, Y.
Sato, K.
Saito, T.
Ito, S.
Masuda, T.
Niida, A.
Suzuki, M.
Baba, H.
Ito, T.
Akimitsu, N.
Kodera, Y.
Mimori, K., Pan-cancer methylome analysis for cancer diagnosis and classification of cancer cell of origin, Cancer Gene Ther. , 2022;29(5):428-36., 2022.06. |
| 4. |
Soyama, H.
Nishio, M.
Otani, J.
Sakuma, T.
Takao, S.
Hara, S.
Masuda, T.
Mimori, K.
Toyokuni, S.
Lydon, J. P.
Nakao, K.
Nishina, H.
Fukumoto, T.
Maehama, T.
Suzuki, A., Hippo-TAZ signaling is the master regulator of the onset of triple-negative basal-like breast cancers, Proc Natl Acad Sci U S A. , 2022;119(29):e2123134119., 2022.06. |
| 5. |
Sugimachi, K.
Araki, H.
Saito, H.
Masuda, T.
Miura, F.
Inoue, K.
Shimagaki, T.
Mano, Y.
Iguchi, T.
Morita, M.
Toh, Y.
Yoshizumi, T.
Ito, T.
Mimori, K., Persistent epigenetic alterations in transcription factors after a sustained virological response in hepatocellular carcinoma, JGH Open. , 2022;6(12):854-63., 2022.06. |
| 6. |
Takahashi, J.
Masuda, T.
Kitagawa, A.
Tobo, T.
Nakano, Y.
Abe, T.
Ando, Y.
Kosai, K.
Kobayashi, Y.
Matsumoto, Y.
Yoshizumi, T.
Mori, M.
Mimori, K., Fanconi Anemia Complementation Group E, a DNA Repair-Related Gene, Is a Potential Marker of Poor Prognosis in Hepatocellular Carcinoma, Oncology. , 2022;100(2):101-13., 2022.06. |
| 7. |
Ueo, H.
Minoura, I.
Ueo, H.
Gamachi, A.
Kai, Y.
Kubota, Y.
Doi, T.
Yamaguchi, M.
Yamashita, T.
Tsuda, H.
Moriya, T.
Yamaguchi, R.
Kozuka, Y.
Sasaki, T.
Masuda, T.
Urano, Y.
Mori, M.
Mimori, K., Development of an intraoperative breast cancer margin assessment method using quantitative fluorescence measurements, Sci Rep. , 2022;12(1):8520., 2022.06. |
| 8. |
Kitagawa, A.
Osawa, T.
Noda, M.
Kobayashi, Y.
Aki, S.
Nakano, Y.
Saito, T.
Shimizu, D.
Komatsu, H.
Sugaya, M.
Takahashi, J.
Kosai, K.
Takao, S.
Motomura, Y.
Sato, K.
Hu, Q.
Fujii, A.
Wakiyama, H.
Tobo, T.
Uchida, H.
Sugimachi, K.
Shibata, K.
Utsunomiya, T.
Kobayashi, S.
Ishii, H.
Hasegawa, T.
Masuda, T.
Matsui, Y.
Niida, A.
Soga, T.
Suzuki, Y.
Miyano, S.
Aburatani, H.
Doki, Y.
Eguchi, H.
Mori, M.
Nakayama, K. I.
Shimamura, T.
Shibata, T.
Mimori, K., Convergent genomic diversity and novel BCAA metabolism in intrahepatic cholangiocarcinoma, Br J Cancer. , 2023., 2023.01. |
| 9. |
Masuda, T.
Ueo, H.
Okumura, Y.
Kai, Y.
Ando, Y.
Masuguchi, K.
Kitagawa, M.
Kitagawa, A.
Hayashi, N.
Tsuruda, Y.
Hisamatsu, Y.
Suehiro, S.
Ohmura, H.
Fujiyoshi, K.
Tanaka, F.
Mimori, K., Dynamic Changes in Peripheral Systemic Immunity Markers During Chemotherapy in HER2-negative Advanced Breast Cancer, Cancer Genomics Proteomics. , 2023;20(2):182-94., 2023.03. |
| 10. |
Nagayama, S.
Kobayashi, Y.
Fukunaga, M.
Sakimura, S.
Sugimachi, K.
Sasaki, S.
Masuda, T.
Mafune, K. I.
Oshima, M.
Shibata, T.
Suzuki, Y.
Mimori, K., Mutated genes on ctDNA detecting postoperative recurrence presented reduced neoantigens in primary tumors in colorectal cancer cases, Sci Rep. , 2023;13(1):1366., 2023.01. |
| 11. |
Nambara, S.
Masuda, T.
Hirose, K.
Hu, Q.
Tobo, T.
Ozato, Y.
Kurashige, J.
Hiraki, Y.
Hisamatsu, Y.
Iguchi, T.
Sugimachi, K.
Oki, E.
Yoshizumi, T.
Mimori, K., Rab27b, a Regulator of Exosome Secretion, Is Associated With Peritoneal Metastases in Gastric Cancer, Cancer Genomics Proteomics. , 2023;20(1):30-9., 2023.01. |
| 12. |
Ohmura, Hirofumi
Masuda, Takaaki
Mimori, Koshi
Baba, Eishi
Horiuchi, Takahiko, A case of malignant phyllodes tumor that responded to pazopanib and developed pneumothorax, Int Cancer Conf J. , 2023;12(1):31-5., 2023.01. |
| 13. |
Otsu, Hajime
Nambara, Sho
Hu, Qingjiang
Hisamatsu, Yuichi
Toshima, Takeo
Takeishi, Kazuki
Yonemura, Yusuke
Masuda, Takaaki
Oki, Eiji
Mimori, Koshi, Identification of serum microRNAs as potential diagnostic biomarkers for detecting precancerous lesions of gastric cancer, Ann Gastroenterol Surg. , 2023;7(1):63-70., 2023.01. |
| 14. |
Ozato, Yuki
Kojima, Yasuhiro
Kobayashi, Yuta
Hisamatsu, Yuuichi
Toshima, Takeo
Yonemura, Yusuke
Masuda, Takaaki
Kagawa, Kouichi
Goto, Yasuhiro
Utou, Mitsuaki
Fukunaga, Mituko
Gamachi, Ayako
Imamura, Kiyomi
Kuze, Yuta
Zenkoh, Junko
Suzuki, Ayako
Niida, Atsushi
Hirose, Haruka
Hayashi, Shuto
Koseki, Jun
Oki, Eiji
Fukuchi, Satoshi
Murakami, Kazunari
Tobo, Taro
Nagayama, Satoshi
Uemura, Mamoru
Sakamoto, Takeharu
Oshima, Masanobu
Doki, Yuichiro
Eguchi, Hidetoshi
Mori, Masaki
Iwasaki, Takeshi
Oda, Yoshinao
Shibata, Tatsuhiro
Suzuki, Yutaka
Shimamura, Teppei
Mimori, Koshi, Spatial and single-cell transcriptomics decipher the cellular environment containing HLA-G+ cancer cells and SPP1+ macrophages in colorectal cancer., Cell Rep. , 2023;42(1):111929., 2023.01. |
| 15. |
Yoshikawa, Y.
Fukunaga, M.
Takahashi, J.
Shimizu, D.
Masuda, T.
Mizushima, T.
Yamada, K.
Mori, M.
Eguchi, H.
Doki, Y.
Ochiya, T.
Mimori, K., Identification of the Minimum Combination of Serum microRNAs to Predict the Recurrence of Colorectal Cancer Cases, Ann Surg Oncol. , 2023;30(1):233-43., 2023.01. |
| 16. |
Sakimura S, Nagayama S, Fukunaga M, Hu Q, Kitagawa A, Kobayashi Y, Hasegawa T, Noda M, Kouyama Y, Shimizu D, Saito T, Niida A, Tsuruda Y, Otsu H, Matsumoto Y, Uchida H, Masuda T, Sugimachi K, Sasaki S, Yamada K, Takahashi K, Innan H, Suzuki Y, Nakamura H, Totoki Y, Mizuno S, Ohshima M, Shibata T, Mimori K., Impaired tumor immune response in metastatic tumors is a selective pressure for neutral evolution in CRC cases. , PLoS Genet. , 2021;17(1):e1009113., 2021.01. |
| 17. |
Takahashi J, Masuda T, Kitagawa A, Tobo T, Nakano Y, Abe T, Ando Y, Kosai K, Kobayashi Y, Matsumoto Y, Yoshizumi T, Mori M, Mimori K. , Fanconi Anemia Complementation Group E, a DNA Repair-Related Gene, Is a Potential Marker of Poor Prognosis in Hepatocellular Carcinoma. , Oncology. , 2022;100(2):101-13., 2021.11. |
| 18. |
Fujii A, Masuda T, Iwata M, Tobo T, Wakiyama H, Koike K, Kosai K, Nakano T, Kuramitsu S, Kitagawa A, Sato K, Kouyama Y, Shimizu D, Matsumoto Y, Utsunomiya T, Ohtsuka T, Yamanishi Y, Nakamura M, Mimori K. , The novel driver gene ASAP2 is a potential druggable target in pancreatic cancer. , Cancer Sci. , 2021;112(4):1655-68., 2021.04. |
| 19. |
Fukunaga M, Mimori K, Masuda T, Hu Q, Yamada K, Mori M. , Postoperative elevation in the plasma CCL2 level is a predictive biomarker of colorectal cancer recurrence. , Surg Today. , 2021;51(10):1671-81., 2021.10. |
| 20. |
Hirata H, Niida A, Kakiuchi N, Uchi R, Sugimachi K, Masuda T, Saito T, Kageyama SI, Motomura Y, Ito S, Yoshitake T, Tsurumaru D, Nishimuta Y, Yokoyama A, Hasegawa T, Chiba K, Shiraishi Y, Du J, Miura F, Morita M, Toh Y, Hirakawa M, Shioyama Y, Ito T, Akimoto T, Miyano S, Shibata T, Mori M, Suzuki Y, Ogawa S, Ishigami K, Mimori K. , The Evolving Genomic Landscape of Esophageal Squamous Cell Carcinoma Under Chemoradiotherapy. , Cancer Res. , 2021;81(19):4926-38., 2021.08. |
| 21. |
Hu Q, Masuda T, Koike K, Sato K, Tobo T, Kuramitsu S, Kitagawa A, Fujii A, Noda M, Tsuruda Y, Otsu H, Kuroda Y, Ito S, Oki E, Mimori K. , Oxysterol binding protein-like 3 (OSBPL3) is a novel driver gene that promotes tumor growth in part through R-Ras/Akt signaling in gastric cancer. , Sci Rep. , 2021;11(1):19178., 2021.09. |
| 22. |
Hu Q, Nonaka K, Wakiyama H, Miyashita Y, Fujimoto Y, Jogo T, Hokonohara K, Nakanishi R, Hisamatsu Y, Ando K, Kimura Y, Masuda T, Oki E, Mimori K, Oda Y, Mori M. , Cytolytic activity score as a biomarker for antitumor immunity and clinical outcome in patients with gastric cancer. , Cancer Med. , 2021;10(9):3129-38., 2021.05. |
| 23. |
Kobayashi Y, Masuda T, Fujii A, Shimizu D, Sato K, Kitagawa A, Tobo T, Ozato Y, Saito H, Kuramitsu S, Noda M, Otsu H, Mizushima T, Doki Y, Eguchi H, Mori M, Mimori K, Mitotic checkpoint regulator RAE1 promotes tumor growth in colorectal cancer, Cancer Sci. , 2021;112(8):3173-89., 2021.06. |
| 24. |
Ueo H, Ueo H, Minoura I, Gamachi A, Doi T, Yamaguchi M, Yamashita T, Tsuda H, Moriya T, Yamaguchi R, Kozuka Y, Sasaki T, Masuda T, Kai Y, Kubota Y, Urano Y, Mori M, Mimori K, Clinical usefulness of a novel fluorescence technique for the intraoperative diagnosis of surgical margins in patients with breast cancer, Br J Surg, 2021;108(10):e340-e2., 2021.08. |
| 25. |
Koike K, Masuda T, Sato K, Fujii A, Wakiyama H, Tobo T, Takahashi J, Motomura Y, Nakano T, Saito H, Matsumoto Y, Otsu H, Takeishi K, Yonemura Y, Mimori K, Nakagawa T, GET4 is a novel driver gene in colorectal cancer that regulates the localization of BAG6, a nucleocytoplasmic shuttling protein, Cancer Sci, 2022;113(1):156-69, 2022.01. |
| 26. |
Kuramitsu S, Masuda T, Hu Q, Tobo T, Yashiro M, Fujii A, Kitagawa A, Abe T, Otsu H, Ito S, Oki E, Mori M, Mimori K, Cancer-associated Fibroblast-derived Spondin-2 Promotes Motility of Gastric Cancer Cells, Cancer Genomics Proteomics, 2021;18(4):521-9, 2021.07. |
| 27. |
Masuda T, Niizeki O, Niizeki T, Fujiyoshi K, Ando Y, Niizeki H, Mimori K., Successful Treatment with Hepatic Arterial Infusion Chemotherapy in a Breast Cancer Patient with Multiple Liver Metastases Who Declined Systemic Therapy, Case Rep Oncol, 2021;14(3):1261-5, 2021.08. |
| 28. |
Masuda T, Mimori K, Artificial intelligence-assisted drug repurposing via "chemical-induced gene expression ranking", Patterns (N Y)., 2022;3(4):100470, 2022.03. |
| 29. |
Takaaki Masuda, “DNA Binding Region” of BRCA1 Affects Genetic Stability through modulating the Intra-S-Phase Checkpoint, 2016.01. |
| 30. |
Takaaki Masuda, Circulating exosomal MicroRNA-203 is associated with metastasis possibly via inducing tumor-associated macrophages in colorectal cancer, 2017.07. |
| 31. |
Takaaki Masuda1, Yoshiaki Shinden1, Miwa Noda1, Hiroki Ueo1,2, Qingjiang Hu1, Yukihiro Yoshikawa1, Yusuke Tsuruda1, Yosuke Kuroda1, Shuhei Ito1, Hidetoshi Eguchi1, Shinji Ohno3, and Koshi Mimori1, Circulating pre-microRNA-488 in peripheral blood is a potential biomarker for predicting recurrence in breast cancer, 2018.07. |
| 32. |
Masuda, T. Ueo, H. Kai, Y. Noda, M. Hu, Q. Sato, K. Fujii, A. Hayashi, N. Tsuruda, Y. Otsu, H. Kuroda, Y. Eguchi, H. Ohno, S. Mimori, K. Ueo, H., N-Cadherin mRNA Levels in Peripheral Blood Could Be a Potential Indicator of New Metastases in Breast Cancer: A Pilot Study., 2020.01. |
| 33. |
Masuda T, Tsuruda Y, Matsumoto Y, Uchida H, Nakayama KI, Mimori K, Drug repositioning in cancer: The current situation in Japan. , 2020.01. |
| 34. |
Masuda, T. Noda, M. Kogawa, T. Kitagawa, D. Hayashi, N. Jomori, T. Nakanishi, Y. Nakayama, K.I. Ohno, S. Mimori, K., Phase I dose-escalation trial to repurpose propagermanium, an oral CCL2 inhibitor, in patients with breast cancer., 2020.01. |
| 35. |
Masuda, T. Noda, M. Kitagawa, A. Hu, Q. Fujii, A. Ito, S. Kosai, K. Ando, Y. Matsumoto, Y. Ohtsu, H. Uchida, H. Ohno, S. Mimori, K, The Expression Level of PD-L1 (CD274) mRNA in Peripheral Blood Is a Potential Biomarker for Predicting Recurrence in Breast Cancer, Anticancer Res, Anticancer Res 2020, 40, 3733-3742, 2020.05. |
| 36. |
Masuda T, Nonami A, Tanaka F, Ando Y, Eto M, Mimori K, A case of a patient receiving combination therapy with paclitaxel plus bevacizumab and adoptive activated alphabeta T-cell immunotherapy in advanced breast cancer, Breast J, 2020.05. |
